Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 10Unknown 9Recruiting 5Terminated 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasm Metastasis 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 391Carboplatin 344Gemcitabine 332pembrolizumab 331Cisplatin 328Paclitaxel 298Radiotherapy 297Docetaxel 287Bevacizumab 253Rituximab 234Capecitabine 224Nivolumab 222Dexamethasone 206Fluorouracil 190fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 134Cetuximab 130fludarabine phosphate 129Bortezomib 129Lenalidomide 126Filgrastim 120Erlotinib Hydrochloride 120Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × FOLFOXIRI protocol × Clear all
NCT03117972 2025-02-05

CLavSyn

Centre Hospitalier Universitaire de Besancon

Phase 2 Terminated
54 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated
107 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡